232 related articles for article (PubMed ID: 20237156)
21. NUP98-PHF23 fusion is recurrent in acute myeloid leukemia and shares gene expression signature of leukemic stem cells.
Ho H; Skaist AM; Pallavajjala A; Yonescu R; Batista D; Wheelan SJ; Ning Y
Leuk Res; 2016 Jun; 45():1-7. PubMed ID: 27060678
[TBL] [Abstract][Full Text] [Related]
22. NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2.
Lahortiga I; Belloni E; Vázquez I; Agirre X; Larrayoz MJ; Vizmanos JL; Valgañón M; Zudaire I; Sáez B; Mateos MC; Di Fiore PP; Calasanz MJ; Odero MD
Cancer Genet Cytogenet; 2005 Mar; 157(2):151-6. PubMed ID: 15721637
[TBL] [Abstract][Full Text] [Related]
23. The HOXD11 gene is fused to the NUP98 gene in acute myeloid leukemia with t(2;11)(q31;p15).
Taketani T; Taki T; Shibuya N; Ito E; Kitazawa J; Terui K; Hayashi Y
Cancer Res; 2002 Jan; 62(1):33-7. PubMed ID: 11782354
[TBL] [Abstract][Full Text] [Related]
24. Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.
Hirose K; Abramovich C; Argiropoulos B; Humphries RK
Oncogene; 2008 Oct; 27(46):6056-67. PubMed ID: 18604245
[TBL] [Abstract][Full Text] [Related]
25. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
26. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
27. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
[TBL] [Abstract][Full Text] [Related]
28. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
29. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
[TBL] [Abstract][Full Text] [Related]
30. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes.
Palmqvist L; Pineault N; Wasslavik C; Humphries RK
PLoS One; 2007 Aug; 2(8):e768. PubMed ID: 17712416
[TBL] [Abstract][Full Text] [Related]
31. Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.
Gu BW; Wang Q; Wang JM; Xue YQ; Fang J; Wong KF; Chen B; Shi ZZ; Shi JY; Bai XT; Wu DH; Chen Z; Chen SJ
Leukemia; 2003 Sep; 17(9):1858-64. PubMed ID: 12970787
[TBL] [Abstract][Full Text] [Related]
32. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract][Full Text] [Related]
33. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
34. Nup98 regulation of histone methylation promotes normal gene expression and may drive leukemogenesis.
Sump B; Brickner JH
Genes Dev; 2017 Nov; 31(22):2201-2203. PubMed ID: 29284709
[TBL] [Abstract][Full Text] [Related]
35. Nup98 is a mobile nucleoporin with transcription-dependent dynamics.
Griffis ER; Altan N; Lippincott-Schwartz J; Powers MA
Mol Biol Cell; 2002 Apr; 13(4):1282-97. PubMed ID: 11950939
[TBL] [Abstract][Full Text] [Related]
36. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation.
Pan Q; Zhu YJ; Gu BW; Cai X; Bai XT; Yun HY; Zhu J; Chen B; Weng L; Chen Z; Xue YQ; Chen SJ
Oncogene; 2008 May; 27(24):3414-23. PubMed ID: 18084320
[TBL] [Abstract][Full Text] [Related]
37. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13).
Taketani T; Taki T; Shibuya N; Kikuchi A; Hanada R; Hayashi Y
Cancer Res; 2002 Aug; 62(16):4571-4. PubMed ID: 12183408
[TBL] [Abstract][Full Text] [Related]
38. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
39. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
40. In vivo analysis of human nucleoporin repeat domain interactions.
Xu S; Powers MA
Mol Biol Cell; 2013 Apr; 24(8):1222-31. PubMed ID: 23427268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
